Mentax

Active Ingredient(s): Butenafine
FDA Approved: * October 18, 1996
Pharm Company: * MYLAN BERTEK
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Mentax Overview

Butenafine hydrochloride is a synthetic benzylamine antifungal, marketed under the trade names Mentax, Butop (India) and is the active ingredient in Lotrimin Ultra. It is structurally related to synthetic allylamine antifungals such as terbinafine. Contents 1 Medical uses 2 Pharmacology 3 Typical usage 4 References Medical uses Butenafine is indicated for the topical treatment of tinea (pityriasis) versicolor due to Malassezia furfur, as well as athlete's foot (Tinea pedis), ringworm...

Read more Mentax Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Butenafine

Recent Mentax Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Mentax: (1 result)

Sorted by National Drug Code

• 0378-6151 Mentax 10 mg/g Topical Cream by Mylan Pharmaceuticals Inc.

Other drugs which contain Butenafine or a similar ingredient: (4 results)

• BUTENAFINE 1 discussion
• LOTRIMIN ULTRA Butenafine
• MENTAX-TC Butenafine Hydrochloride
• BETAMETHASONE + BUTENAFINE